CLINICAL_TRIALS
trial_result
· 2019-12-09
Clinical Trial Update: Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension [Phase 2]
Summary
Phase 2 clinical trial evaluating an estrogen receptor antagonist in patients with pulmonary arterial hypertension has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Pennsylvania | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-12-09